AMNEAL PHARMACEUTICALS, INC. Gain (Loss) Related to Litigation Settlement
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Gain (Loss) Related to Litigation Settlement of -$8.06 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for the quarter ending 2026-06-30 was -$8.06M, a 2165.90% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for the quarter ending 2026-03-31 was -$694.00K.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for fiscal 2025 was $390.00K.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for fiscal 2024 was -$96.69M.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for fiscal 2023 was -$1.82M.
- AMNEAL PHARMACEUTICALS, INC. gain (loss) related to litigation settlement for fiscal 2022 was -$269.93M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 3 month as first filed | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 9 month as first filed | Gain (Loss) Related to Litigation Settlement 12 month | Gain (Loss) Related to Litigation Settlement 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.06M 10-Q · filed 2026-08-06 | -$8.75M 10-Q · filed 2026-08-06 | -$8.75M derived: sum of 3 quarters · filed 2026-08-06 | -$8.75M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$694.00K 10-Q · filed 2026-05-07 | -$694.00K derived: sum of 2 quarters · filed 2026-05-07 | -$694.00K derived: sum of 3 quarters · filed 2026-05-07 | -$304.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $390.00K derived: sum of 3 quarters · filed 2026-08-06 | $390.00K 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $390.00K derived: sum of 2 quarters · filed 2026-08-06 | $390.00K 10-Q · filed 2025-11-06 | -$1.39M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $390.00K 10-Q · filed 2026-08-06 | $390.00K 10-Q · filed 2026-08-06 | -$1.39M derived: sum of 3 quarters · filed 2026-08-06 | -$1.24M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$1.78M derived: sum of 2 quarters · filed 2026-05-07 | -$1.63M derived: sum of 3 quarters · filed 2026-05-07 | -$2.33M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.63M derived: sum of 2 quarters · filed 2026-02-27 | -$2.33M derived: sum of 3 quarters · filed 2026-02-27 | -$96.69M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $149.00K 10-Q · filed 2025-11-06 | -$550.00K derived: sum of 2 quarters · filed 2025-11-06 | -$94.91M 10-Q · filed 2025-11-06 | -$97.77M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | -$699.00K 10-Q · filed 2025-08-07 | -$95.06M 10-Q · filed 2025-08-07 | -$97.92M derived: sum of 3 quarters · filed 2026-02-27 | -$95.30M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | -$94.36M 10-Q · filed 2025-05-07 | -$97.22M derived: sum of 2 quarters · filed 2026-02-27 | -$94.60M derived: sum of 3 quarters · filed 2026-02-27 | -$96.62M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | -$2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$243.00K derived: sum of 2 quarters · filed 2026-02-27 | -$2.26M derived: sum of 3 quarters · filed 2026-02-27 | -$1.82M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $2.62M 10-Q · filed 2024-11-12 | $603.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.04M 10-Q · filed 2024-11-12 | -$19.05M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | -$2.02M 10-Q · filed 2024-08-09 | -$1.58M 10-Q · filed 2024-08-09 | -$21.68M derived: sum of 3 quarters · filed 2025-02-28 | -$21.96M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $436.00K 10-Q · filed 2024-05-08 | -$19.66M derived: sum of 2 quarters · filed 2025-02-28 | -$19.94M derived: sum of 3 quarters · filed 2025-02-28 | -$271.82M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | -$20.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$20.38M derived: sum of 2 quarters · filed 2025-02-28 | -$272.26M derived: sum of 3 quarters · filed 2025-02-28 | -$269.93M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$285.00K 10-Q · filed 2023-11-09 | -$252.16M derived: sum of 2 quarters · filed 2023-11-09 | -$249.84M 10-Q · filed 2023-11-09 | -$255.84M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | -$251.88M 10-Q · filed 2023-08-08 | -$249.55M 10-Q · filed 2023-08-08 | -$255.55M derived: sum of 3 quarters · filed 2024-03-14 | -$274.55M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | $2.33M 10-Q · filed 2023-05-09 | -$3.67M derived: sum of 2 quarters · filed 2024-03-14 | -$22.67M derived: sum of 3 quarters · filed 2024-03-14 | -$22.67M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$25.00M derived: sum of 2 quarters · filed 2024-03-14 | -$25.00M derived: sum of 3 quarters · filed 2024-03-14 | -$25.00M 10-K · filed 2024-03-14 | |||
| 2021-09-30 | -$19.00M 10-Q · filed 2022-11-07 | -$19.00M derived: sum of 2 quarters · filed 2022-11-07 | -$19.00M 10-Q · filed 2022-11-07 | -$19.00M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-03 | -$60.00K derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | -$60.00K derived: sum of 3 quarters · filed 2023-03-03 | -$1.36M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$60.00K derived: sum of 2 quarters · filed 2023-03-03 | -$1.36M derived: sum of 3 quarters · filed 2023-03-03 | -$5.86M 10-K · filed 2023-03-03 | |||
| 2020-09-30 | -$60.00K 10-Q · filed 2021-11-08 | -$1.36M derived: sum of 2 quarters · filed 2021-11-08 | -$5.86M 10-Q · filed 2021-11-08 | -$3.55M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$1.30M 10-Q · filed 2021-08-09 | -$5.80M 10-Q · filed 2021-08-09 | -$3.49M derived: sum of 3 quarters · filed 2022-03-01 | -$18.24M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$4.50M 10-Q · filed 2021-05-07 | -$2.19M derived: sum of 2 quarters · filed 2022-03-01 | -$16.94M derived: sum of 3 quarters · filed 2022-03-01 | -$16.94M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$12.44M derived: sum of 2 quarters · filed 2022-03-01 | -$12.44M derived: sum of 3 quarters · filed 2022-03-01 | -$12.44M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$14.75M 10-Q · filed 2020-11-06 | -$14.75M derived: sum of 2 quarters · filed 2020-11-06 | -$14.75M 10-Q · filed 2020-11-06 | $4.55M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $19.30M derived: sum of 3 quarters · filed 2021-03-01 | $16.71M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $19.30M derived: sum of 2 quarters · filed 2021-03-01 | $16.71M derived: sum of 3 quarters · filed 2021-03-01 | $19.71M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $16.71M derived: sum of 2 quarters · filed 2021-03-01 | $19.71M derived: sum of 3 quarters · filed 2021-03-01 | $19.71M 10-K · filed 2021-03-01 | $22.30M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | -$2.59M 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2018-11-07 | $411.00K derived: sum of 2 quarters · filed 2019-11-07 | $411.00K 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $3.00M 10-Q · filed 2019-08-05 | $3.00M 10-Q · filed 2019-08-05 | |||||
| 2017-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $29.31M derived: sum of 2 quarters · filed 2020-03-02 | $29.31M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $21.47M 10-Q · filed 2018-11-07 | $21.47M 10-Q · filed 2018-11-07 | |||||
| 2016-12-31 | $11.00M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |